![White car (Porsche Taycan) with the hood popped is inside the building with an american flag on the wall.](/sites/default/files/styles/featured_square_large/public/2024-06/2024-P09317.jpg?h=8f9cfe54&itok=m6sQhZRq)
Filter News
Area of Research
- Advanced Manufacturing (3)
- Biology and Environment (17)
- Building Technologies (1)
- Clean Energy (27)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (3)
- Fusion and Fission (1)
- Isotopes (2)
- Materials (4)
- Materials for Computing (7)
- Mathematics (1)
- National Security (1)
- Neutron Science (4)
- Quantum information Science (3)
- Supercomputing (9)
News Topics
- (-) Biomedical (10)
- (-) Clean Water (8)
- (-) Frontier (4)
- (-) Machine Learning (1)
- (-) Polymers (5)
- (-) Quantum Science (12)
- (-) Sustainable Energy (35)
- 3-D Printing/Advanced Manufacturing (26)
- Advanced Reactors (2)
- Artificial Intelligence (7)
- Big Data (5)
- Bioenergy (13)
- Biology (23)
- Biotechnology (5)
- Buildings (13)
- Chemical Sciences (7)
- Climate Change (11)
- Composites (6)
- Computer Science (30)
- Coronavirus (10)
- Critical Materials (4)
- Cybersecurity (5)
- Decarbonization (7)
- Energy Storage (22)
- Environment (39)
- Exascale Computing (2)
- Fusion (8)
- Grid (11)
- High-Performance Computing (19)
- Isotopes (12)
- ITER (4)
- Materials (32)
- Materials Science (22)
- Mathematics (1)
- Mercury (3)
- Microscopy (10)
- Nanotechnology (10)
- National Security (7)
- Net Zero (1)
- Neutron Science (18)
- Nuclear Energy (6)
- Physics (3)
- Quantum Computing (5)
- Security (3)
- Space Exploration (4)
- Statistics (1)
- Summit (9)
- Transportation (21)
Media Contacts
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Oak Ridge National Laboratory’s MENNDL AI software system can design thousands of neural networks in a matter of hours. One example uses a driving simulator to evaluate a network’s ability to perceive objects under various lighting conditions. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/CARLA%20MENNDL%20sim001_1.png?h=e2caa22a&itok=tvE9seMo)
The Department of Energy’s Oak Ridge National Laboratory has licensed its award-winning artificial intelligence software system, the Multinode Evolutionary Neural Networks for Deep Learning, to General Motors for use in vehicle technology and design.
![Jianlin Li, leader of the Energy Storage and Conversion Manufacturing Group, directs the development of advanced manufacturing schemes and pilot-scale devices into emerging energy storage and conversion research. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/li_page_0.jpg?h=2fa54098&itok=R3PZZ32f)
In his career focused on energy storage science, Jianlin Li has learned that discovering new ways to process and assemble batteries is just as important as the development of new materials.
![INCITE logo](/sites/default/files/styles/list_page_thumbnail/public/2021-04/INCITE_2021.png?h=ae114f5c&itok=JWYnqxg5)
The U.S. Department of Energy’s Innovative and Novel Computational Impact on Theory and Experiment, or INCITE, program is seeking proposals for high-impact, computationally intensive research campaigns in a broad array of science, engineering and computer science domains.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![Parans Paranthaman, a researcher in the Chemical Sciences Division at ORNL, coordinated research efforts to study the filter efficiency of the N95 material. His published results represent one of the first studies on polypropylene as it relates to COVID-19. Credit: ORNL/U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P01675.jpg?h=18f5407d&itok=B3UCcJxT)
When COVID-19 was declared a pandemic in March 2020, Oak Ridge National Laboratory’s Parans Paranthaman suddenly found himself working from home like millions of others.
![Spin chains in a quantum system undergo a collective twisting motion as the result of quasiparticles clustering together. Demonstrating this KPZ dynamics concept are pairs of neighboring spins, shown in red, pointing upward in contrast to their peers, in blue, which alternate directions. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/1_full%5B2%5D.png?h=d1cb525d&itok=l8KtOI25)
Using complementary computing calculations and neutron scattering techniques, researchers from the Department of Energy’s Oak Ridge and Lawrence Berkeley national laboratories and the University of California, Berkeley, discovered the existence of an elusive type of spin dynamics in a quantum mechanical system.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/gif_high_res.gif?h=ae1281eb&itok=QtNBjm3O)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/after_transprent_background-wFill.png?h=c71d0c67&itok=jGFt_Ggj)
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.